...
首页> 外文期刊>Journal of Clinical Microbiology >Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG Test for Diagnosis of Neisseria gonorrhoeae Infection in a Low-Prevalence Population
【24h】

Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG Test for Diagnosis of Neisseria gonorrhoeae Infection in a Low-Prevalence Population

机译:通过16S rRNA PCR确认COBAS AMPCTOR CT / NG检测用于诊断低流行人群中淋病奈瑟菌

获取原文

摘要

The COBAS AMPLICOR CT/NG test is widely used for the diagnosis of Neisseria gonorrhoeae infection using genital swabs or urine samples. Although highly specific, cross-reactivity occurs with some nonpathogenic strains of Neisseria and Lactobacillus species. In low-prevalence populations, even highly specific assays may require confirmatory testing of positive results. We assessed the positive predictive value (PPV) of this test in a low-prevalence (0.5%) setting. Genital and urine specimens testing positive using the COBAS AMPLICOR NG test were retested using an investigational 16S rRNA PCR assay. Additionally, 737 specimens were tested in parallel by both culture and the above PCR protocol. Of 9,772 specimens tested in-house, 168 were positive by the AMPLICOR test; in addition, 62 AMPLICOR-positive specimens were referred to our laboratory for confirmatory testing, yielding 230 positive specimens. Of these, 72 were confirmed positive by 16S rRNA PCR, yielding a specificity of 98.7% and a PPV of 31.3%. Specificity was similar for all specimen types, whereas PPV varied with prevalence: specimens from males, females, urine specimens, and genital swabs had PPVs of 70.8, 13.3, 51.9, and 20.1%, respectively. The PPV was higher when the initial AMPLICOR optical density (OD) was ≥3.5 versus initial and repeat OD readings in an equivocal zone of ≥0.2 to <3.5 (65.1 versus 10.1%; P < 0.001). On repeat testing of specimens with ODs in the equivocal zone, 54 gave ODs of ≥0.2 and <2.0, 35 gave ODs of ≥2.0 and <3.5, and 12 gave ODs of ≥3.5, with 3.7, 20, and 33.3% confirmed positive, respectively (P = 0.004). Comparing PCR to culture as the “gold standard,” specificity increased from 96.8 to 99.9% when 16S rRNA PCR was performed on specimens positive by the COBAS AMPLICOR NG test. Confirmatory testing with a more specific method such as 16S rRNA PCR should be considered in low-prevalence populations, especially for specimens with an OD in the equivocal zone.
机译:COBAS AMPLICOR CT / NG测试被广泛用于使用生殖器拭子或尿液样本诊断淋病奈瑟氏菌。尽管具有高度特异性,但交叉反应会与某些非致病性的奈瑟氏菌和乳杆菌属菌株发生。在低流行人群中,即使是高度特异性的测定也可能需要对阳性结果进行验证性测试。我们在低患病率(0.5%)的情况下评估了该测试的阳性预测值(PPV)。使用COBAS AMPLICOR NG检测呈阳性的生殖器官和尿液样本使用研究性16S rRNA PCR检测法进行了重新检测。另外,通过培养和上述PCR方案对737个标本进行了平行测试。在内部测试的9,772个样本中,有168个通过AMPLICOR测试呈阳性;此外,有62例AMPLICOR阳性标本被转交给我们的实验室进行确认性测试,得出230份阳性标本。其中,通过16S rRNA PCR确认有72例阳性,特异性为98.7%,PPV为31.3%。所有样本类型的特异性均相似,而PPV随患病率而变化:男性,女性,尿液样本和生殖器拭子的样本的PPV分别为70.8%,13.3%,51.9%和20.1%。当初始AMPLICOR光密度(OD)≥3.5时,相对于初始和重复OD读数在≥0.2至<3.5的不确定区域中,PPV更高(65.1对10.1%; P <0.001)。重复测试OD值在模棱两可的区域时,有54 OD值≥0.2和<2.0,有35 OD值≥2.0和<3.5,有12 OD≥3.5,其中3.7、20和33.3%证实为阳性,分别( P = 0.004)。将PCR与培养物作为“黄金标准”进行比较,当对COBAS AMPLICOR NG检测呈阳性的标本进行16S rRNA PCR时,特异性从96.8%提高到99.9%。在低流行人群中,应考虑使用更具体的方法(例如16S rRNA PCR)进行确认性测试,尤其是对于在模糊区域具有OD的标本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号